Clinical Trial Update: The Effect of GLP-1 on the Inhibition of Glucagon Secretion [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of GLP-1 on glucagon secretion in people with Type 1 diabetes mellitus and Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes, Type 1 Diabetes | NA | Status: COMPLETED